Top Menu

Bob Ehrlich

DTC in Perspective: FDA Research Reinforces Warning Rationale

Many recent FDA warning letters involve what they say are distracting visuals during risk discussion. Last year Otezla and Toujeo were cited for that. A recent study using eye tracking reinforced their view that visual backgrounds on TV ads are potentially hurting comprehension of risks. Drug makers frequently mention some of the risks using supers […]

Continue Reading 0
US National Capitol

Healthcare: Repeal Now, Replace Later?

Earlier today, Nebraska Senator Ben Sasse sent a letter to President Trump urging him to separate the actions of repealing and replacing healthcare, rather than doing them simultaneously, if there is still no resolution by July 10th. Since not enough progress has been made on healthcare, during an appearance on Fox & Friends this morning the Republican […]

Continue Reading 0
PRODUCT_Interact

PatientPoint Raises $140 Million in Capital to Fuel Its Digital POC Growth

PatientPoint announced this week that it received $140 million in capital from private investment firms, allowing for significant digital growth in its point of care networks. Serving as a strategic advisor, the Peter J. Solomon Company secured the financing from Searchlight Capital Partners and Silver Point Capital. A leader in patient education and engagement programs […]

Continue Reading 0